©The Author(s) 2025.
World J Diabetes. Nov 15, 2025; 16(11): 111223
Published online Nov 15, 2025. doi: 10.4239/wjd.v16.i11.111223
Published online Nov 15, 2025. doi: 10.4239/wjd.v16.i11.111223
Table 4 Logistic multivariate regression for developing diabetic nephropathy
| Characteristics | Odds ratio | 95% confidence interval | P value |
| Duration (years) | 1.854 | 1.191-2.884 | 0.006 |
| SBP (mmHg) | 1.091 | 1.026-1.160 | 0.005 |
| eGFR (mL/min/1.73 m2) | 0.946 | 0.909-0.986 | 0.008 |
| Scr (μmol/L) | 1.136 | 1.058-1.219 | < 0.001 |
| GSH (nmol/mL) | 0.438 | 0.272-0.703 | 0.001 |
| SLC7A11 (pg/mL) | 0.953 | 0.911-0.998 | 0.041 |
| GPX4 (ng/mL) | 0.925 | 0.885-0.966 | < 0.001 |
| RRM2 (pg/mL) | 0.820 | 0.712-0.945 | 0.006 |
- Citation: Gao CC, Ding FF, Jiang X. RRM2 attenuates the renal tubular ferroptosis in diabetic kidney disease through PI3K/Akt/Nrf2 pathway. World J Diabetes 2025; 16(11): 111223
- URL: https://www.wjgnet.com/1948-9358/full/v16/i11/111223.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i11.111223